References
1. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: A WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323–33
2. O’Brien KL, Shainker SA, Lockhart EL. Transfusion management of obstetric hemorrhage. Transfus Med Rev. 2018;32(4):249–55
3. Weeks A. The prevention and treatment of postpartum haemorrhage: What do we know, and where do we go to next? BJOG. 2015;122(2):202–10
4. Committee on Practice Bulletins – Obstetrics. Practice Bulletin number 183. Practice Bulletin No. 183: Postpartum hemorrhage. Obstet Gynecol. 2017;130(4):e168–86
5. Wang Y, Han W, Pan L, Wang C, Liu Y, Hu W, et al. Impact of COVID-19 on blood centres in Zhejiang Province China. Vox Sang. 2020
6. Baron DM, Franchini M, Goobie SM, Javidroozi M, Klein AA, Lasocki S, et al. Patient blood management during the COVID-19 pandemic: A narrative review. Anaesthesia. 2020
7. Sakai H. Overview of potential clinical applications of hemoglobin vesicles (HbV) as artificial red cells, evidenced by preclinical studies of the Academic Research Consortium. J Funct Biomater. 2017;8(1):10
8. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A meta-analysis. JAMA. 2008;299(19):2304–12
9. Chang TM. Semipermeable microcapsules. Science. 1964;146(3643):524–5
10. Sakai H, Sou K, Tsuchida E. Hemoglobin-vesicles as an artificial oxygen carrier. Methods Enzymol. 2009;465:363–84
11. Taguchi K, Miyasato M, Ujihira H, Watanabe H, Kadowaki D, Sakai H, et al. Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment. Toxicol Appl Pharmacol. 2010;248(3):234–41
12. Takahashi D, Azuma H, Sakai H, Sou K, Wakita D, Abe H, et al. Phagocytosis of liposome particles by rat splenic immature monocytes makes them transiently and highly immunosuppressive in ex vivo culture conditions. J Pharmacol Exp Ther. 2011;337(1):42–9
13. Sakai H, Suzuki Y, Sou K, Kano M. Cardiopulmonary hemodynamic responses to the small injection of hemoglobin vesicles (artificial oxygen carriers) in miniature pigs. J Biomed Mater Res A.2012;100(10):2668–77
14. Taguchi K, Urata Y, Anraku M, Watanabe H, Kadowaki D, et al. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice. Drug Metab Dispos. 2009;37(11):2197–203
15. Sakai H, Masada Y, Horinouchi H, Ikeda E, Sou K, Takeoka S, et al. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days. J Pharmacol Exp Ther. 2004;311(3):874–84
16. Seishi Y, Horinouchi H, Sakai H, Kobayashi K. Effect of the cellular-type artificial oxygen carrier hemoglobin vesicle as a resuscitative fluid for prehospital treatment: Experiments in a rat uncontrolled hemorrhagic shock model. Shock. 2012;38(2):153–8
17. Hagisawa K, Kinoshita M, Takase B, Hashimoto K, Saitoh D, Seki S, et al. Efficacy of resuscitative transfusion with hemoglobin vesicles in the treatment of massive hemorrhage in rabbits with thrombocytopenic coagulopathy and its effect on hemostasis by platelet transfusion. Shock. 2018;50(3):324–30
18. Tokuno M, Taguchi K, Yamasaki K, Sakai H, Otagiri M. Long-term stored hemoglobin-vesicles, a cellular type of hemoglobin-based oxygen carrier, has resuscitative effects comparable to that for fresh red blood cells in a rat model with massive hemorrhage without post-transfusion lung injury. PLOS ONE. 2016;11(10):e0165557
19. Sakai H, Sou K, Horinouchi H, Kobayashi K, Tsuchida E. Haemoglobin-vesicles as artificial oxygen carriers: Present situation and future visions. J Intern Med. 2008;263(1):4–15
20. Waters JH. Role of the massive transfusion protocol in the management of haemorrhagic shock. Br J Anaesth. 2014;113(Suppl 2):ii3–8
21. Yu YH, Gong SP, Sheng C, Zhao KS, Lodato RF, Wang CH. Increased survival with hypotensive resuscitation in a rabbit model of uncontrolled hemorrhagic shock in pregnancy. Resuscitation.2009;80(12):1424–30
22. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: The ARRIVE Guidelines for Reporting Animal Research. PLOS Biol. 2010;8(6):e1000412
23. Hagisawa K, Kinoshita M, Takikawa M, Takeoka S, Saitoh D, Seki S, et al. Combination therapy using fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes and hemoglobin vesicles for trauma-induced massive hemorrhage in thrombocytopenic rabbits. Transfusion.2019;59(10):3186–96
24. Taguchi K, Watanabe H. A fourteen-day observation and pharmacokinetic evaluation after a massive intravenous infusion of hemoglobin-vesicles (artificial oxygen carriers) in cynomolgus monkeys. J Drug Metab Toxicol. 2012;3(4):128
25. Kawaguchi R, Matsumoto K, Akira S, Ishitani K, Iwasaku K, Ueda Y, et al. Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2017 edition. J Obstet Gynaecol Res. 2019. Japan Society of Obstetrics and Gynecology;45(4):766–86
26. Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol. 2001;21(1):15–23
27. Cannon JW. Hemorrhagic shock. N Engl J Med. 2018;378(4):370–9
28. Faul F, Erdfelder E, Lang AG, Buchner AG. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91
29. Barroso J, Osborne B, Teramura G, Pellham E, Fitzpatrick M, Biehl R, et al. Safety evaluation of a lyophilized platelet-derived hemostatic product. Transfusion.2018;58(12):2969–77
30. Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de Groot CA, et al. Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG. 2014;121(8):1005–14.
31. Chessman J, Patterson J, Nippita T, Drayton B, Ford J. Haemoglobin concentration following postpartum haemorrhage and the association between blood transfusion and breastfeeding: a retrospective cohort study. BMC Res Notes. 2018;11(1):686.
32. Moon PF, Bliss SP, Posner LP, Erb HN, Nathanielsz PW. Fetal oxygen content is restored after maternal hemorrhage and fluid replacement with polymerized bovine hemoglobin, but not with hetastarch, in pregnant sheep. Anesth Analg. 2001;93(1):142–50.
33. Wigger O, Bloechlinger S, Berger D, Häner J, Zanchin T, Windecker S, et al. Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock. Eur Heart J Acute Cardiovasc Care.2018;7(1):45–52
34. Olofsson C, Ahl T, Johansson T, Larsson S, Nellgård P, Ponzer S, et al. A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified hemoglobin (Hemospan) in patients undergoing major orthopedic surgery. Anesthesiology.2006;105(6):1153–63
35. Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG. HBOC-201 as an alternative to blood transfusion: Efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma. 2008;64(6):1484–97
36. Li H, Ohta H, Tahara Y, Nakamura S, Taguchi K, Nakagawa M, et al. Artificial oxygen carriers rescue placental hypoxia and improve fetal development in the rat pre-eclampsia model [sci. rep. :15271]. Sci Rep. 2015;5:15271